New antibiotic dosing method could cut infections after heart surgery
NCT ID NCT07658378
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two ways of giving the antibiotic cefazolin during coronary artery bypass surgery to prevent wound infections. One group gets the drug as a steady drip (continuous infusion), the other as standard short injections. The trial will enroll 100 adults in Egypt and track how many develop a surgical site infection. If the continuous method works better, it could change how antibiotics are given during heart surgery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cefazolin
- What this could lead to
- If continuous infusion works better, it could become a new standard to prevent infections after heart bypass surgery.
- What could go wrong
- This is a small, early-phase trial in one country, so results may not apply everywhere. The difference between the two methods may be small or not meaningful.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURGICAL SITE INFECTION (SSI) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A simple drain may slash wound infections after gynecologic cancer surgery
- Drone Warfare's hidden toll: new study tracks infection risk in combat wounds
- Vacuum bandage may shield ECMO patients from wound infections
- Wound injection may slash infection risk in emergency abdominal surgery
- New rinse aims to cut infection risk in spine surgery
- New recovery plan may cut infections after emergency gut surgery